BMY Revenue 2026

Annual and quarterly sales data for Bristol-Myers Squibb Company

Latest Annual Revenue

$48.19B

2025-12-31

YoY Growth

-0.2%

vs. previous year

4-Year CAGR

1.0%

compound growth

Annual Revenue History

2025-12-31

$48.19B

YoY Growth

-0.2%

2024-12-31

$48.30B

YoY Growth

+7.3%

2023-12-31

$45.01B

YoY Growth

-2.5%

2022-12-31

$46.16B

YoY Growth

-0.5%

2021-12-31

$46.38B

Quarterly Revenue Breakdown

2026-03-31

$11.49B

2025-09-30

$12.22B

2025-06-30

$12.27B

2025-03-31

$11.20B

2024-09-30

$11.89B

2024-06-30

$12.20B

2024-03-31

$11.87B

2023-09-30

$10.97B

Revenue by Segment

Total Revenue$48.19B (100.0%)

Get Full BMY Financial Analysis

View complete income statements, balance sheets, and AI-powered insights

Frequently Asked Questions

What is BMY's revenue?

BMY (Bristol-Myers Squibb Company) reported $48.19 billion in revenue for 2025-12-31. This represents a 0.2% decrease compared to the previous year.

How much revenue does BMY make per year?

Bristol-Myers Squibb Company generates approximately $48.19 billion in annual revenue based on the most recent fiscal year ending 2025-12-31.

Is BMY revenue growing?

BMY's revenue declined 0.2% year-over-year. This could be due to Healthcare sector challenges, market conditions, or business restructuring.

What is BMY's quarterly revenue?

BMY reported $11.49 billion in revenue for the most recent quarter (2026-03-31).

What are BMY's revenue sources?

BMY's revenue comes from multiple segments: Total Revenue. See the revenue breakdown below for detailed segment analysis.

How does BMY compare to competitors in revenue?

BMY generates $48.19 billion in annual revenue in the Healthcare sector. Compare BMY to competitors using our stock comparison tool to see relative market share and growth rates.

What is BMY's revenue per share?

Revenue per share for BMY can be calculated by dividing annual revenue by shares outstanding. Visit our stock analysis page for detailed metrics.

Why is BMY's revenue important for investors?

Revenue (also called sales or top-line) is the total income Bristol-Myers Squibb Company generates from its operations. Revenue growth indicates business expansion and market share gains. For BMY, tracking revenue trends helps investors understand the company's growth trajectory, pricing power, and market position in the Healthcare sector.

What affects BMY's revenue growth?

Key factors affecting BMY's revenue include: market demand, pricing strategy, competitive dynamics, product/service mix, geographic expansion, and macroeconomic conditions.

How to analyze BMY's revenue quality?

To assess BMY's revenue quality, consider: (1) Revenue consistency - is growth sustainable? (2) Revenue sources - diversified or concentrated? (3) Recurring vs one-time revenue - subscription models are more predictable. (4) Customer concentration - dependency on few customers. (5) Currency exposure for international operations.

Disclaimer: Revenue data is based on publicly filed financial statements. Historical performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.

Explore Categories